Latest news
25 items- SECNAYA Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities8-K - INVO Fertility, Inc. (0001417926) (Filer)
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - INVO Fertility, Inc. (0001417926) (Filer)
- SECSEC Form 10-K filed by NAYA Biosciences Inc.10-K - INVO Fertility, Inc. (0001417926) (Filer)
- PRINVO Fertility Confirms New Nasdaq Trading Symbol of "IVF"SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics, today confirmed it will begin trading under the new symbol "IVF" at the market open on April 28, 2025. The CUSIP number for the Company's common stock will remain unchanged. The symbol change follows the Company's announcement on April 14, 2025, regarding the strategic decision to separate its fertility and oncology businesses into distinct operations. "Our new Nasdaq ticker symbol of ‘IVF' reflect
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - INVO Fertility, Inc. (0001417926) (Filer)
- PRNAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed "INVO Fertility, Inc."Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of bifunctional antibodies SARASOTA, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc. (the "Company") (NASDAQ:NAYA), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics, today announced its decision to separate its fertility and oncology operations. This strategic decision to separ
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECSEC Form NT 10-K filed by NAYA Biosciences Inc.NT 10-K - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - NAYA Biosciences, Inc. (0001417926) (Filer)
- PRNAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, and a leading provider of in vitro fertilization (IVF) and in vivo Intravaginal Culture ("IVC") fertility treatments, announced today that it will effect a 1-for-12 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on March 18, 2025. Commencing with the opening of trading on The Nasdaq Capital Market on March 18, 2025, the Company's common stock will trade on a post-split basis un
- SECSEC Form DEFR14A filed by NAYA Biosciences Inc.DEFR14A - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Other Events8-K - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECSEC Form S-8 filed by NAYA Biosciences Inc.S-8 - NAYA Biosciences, Inc. (0001417926) (Filer)
- PRNAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility TreatmentSARASOTA, Fla. and MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, and a leading provider of in vitro fertilization (IVF) and in vivo Intravaginal Culture ("IVC") fertility treatments, proudly supports the U.S. President's recent executive order aimed at reducing the cost of IVF and expanding access to fertility services. The order directs the Domestic Policy Council to develop policy recommendations within 90 days to protect IVF access and significantly lower out-of-pocket expenses and health plan costs for
- PRNAYA Biosciences Announces Nomination of New Board MembersNew board reflects company's added focus on oncology & autoimmune diseases SARASOTA, Fla. and MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, today announced that its board of directors has nominated five new candidates with extensive experience in in the biotechnology industry to be approved at the company shareholder meeting scheduled for March 10th, 2025. Laurent Audoly, PhD is the cofounder and CEO of PriveBio, a precision medicine company, and a professor and strategic advisor at the Institute for Experient
- SECSEC Form DEFA14A filed by NAYA Biosciences Inc.DEFA14A - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECSEC Form DEF 14A filed by NAYA Biosciences Inc.DEF 14A - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECSEC Form PRE 14A filed by NAYA Biosciences Inc.PRE 14A - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECSEC Form 424B4 filed by NAYA Biosciences Inc.424B4 - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECSEC Form EFFECT filed by NAYA Biosciences Inc.EFFECT - NAYA Biosciences, Inc. (0001417926) (Filer)
- PRNAYA Biosciences Announces Pricing of $9.5 Million Public OfferingSARASOTA, Fla. and MIAMI, Jan. 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences ("NAYA") (NASDAQ:NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women's health, today announced the pricing of a public offering of an aggregate of 13,615,171 units at a public offering price of $0.70 per unit. Each unit consists of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock. The warrants will have an exercise price of $0.70 per share, will be exercisable immediately upon issuance, and will expire on the five year anniversary of the original issuance
- SECAmendment: SEC Form S-1/A filed by NAYA Biosciences Inc.S-1/A - NAYA Biosciences, Inc. (0001417926) (Filer)
- SECNAYA Biosciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - NAYA Biosciences, Inc. (0001417926) (Filer)
NAYA FAQ
4 questionsWhere does NAYA stock trade?
NAYA Biosciences Inc. (NAYA) is listed on NASDAQ.What sector and industry is NAYA in?
NAYA Biosciences Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to NAYA?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare NAYA side-by-side with any of them on Quantisnow.How can I track NAYA on Quantisnow?
Quantisnow aggregates NAYA Biosciences Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NAYA to receive live email and push alerts on every new disclosure.